GRADING Congress

Check the drug price grades of other members of Congress.

Chris Coons (D-DE)

Chris Coons


Drug Prices Grade


Contributions 3.0
Soft Data 7.0
Sponsorships 5.0
Votes 5.0
Curve Adjustment* 39.2
Grand Total 59.2

* Please see the full methodology, linked above, for more information about the curve adjustments.

Key Stats

First Election: 2010

Next Election: 2020

Birth Date: 9/09/1963

Donations from Pharma

Donation data provided by the Center for Responsive Politics (
* Includes donations from organizations that are not identified individually in the data set.

NOTE: Amounts listed for the 2020 election cycle represent contributions received to date in the ongoing cycle. Only election cycles from 2018 and earlier will have complete contribution amounts.

Bill Sponsorships

S. 1348, Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017Cosponsor
S. 474 Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019Cosponsor
S. 476 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019Cosponsor
S. 62 Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019Cosponsor

Significant Votes

Azar ConfirmationYea
Dorgan Amdt. No. 2793N/A
S. 2554 Know Drug PricesYea
S. 3 Medicare Negotiation 2007N/A
S.Amdt. 178 to S.Con.Res. 3Nay

N/A = Member was not in Congress during this vote.

Stay informed about news and advocacy centered on the crisis of high drug prices